T. Rowe Price Investment Management, Inc. Sana Biotechnology, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 4,801,847 shares of SANA stock, worth $24.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,801,847Holding current value
$24.4 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding SANA
# of Institutions
156Shares Held
124MCall Options Held
297KPut Options Held
124K-
Flagship Pioneering Inc. Cambridge, MA25MShares$127 Million16.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$61.9 Million0.0% of portfolio
-
Baillie Gifford & CO10.7MShares$54.2 Million0.08% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$51.8 Million0.11% of portfolio
-
Black Rock Inc. New York, NY9.05MShares$46 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $968M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...